GW Pharmaceuticals PLC (GWPH.OQ)
15 Dec 2017
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|60||Executive Chairman of the Board|
|43||1999||Chief Executive Officer, Director|
|55||2007||Non-Executive Deputy Chairman of the Board, Senior Independent Director|
|44||2012||Chief Financial Officer, Company Secretary, Director|
|49||2012||Chief Operating Officer, Executive Director|
- BRIEF-GW Pharmaceuticals Reacquires Full Rights To Develop And Commercialize Sativex In U.S.
- BRIEF-GW Pharmaceuticals Announces Pricing Of Public Offering Of ADSs Raising Gross Proceeds Of $276 Million
- BRIEF-GW Pharmaceuticals Announces Proposed Public Offering Of ADSs
- Zogenix stock soars on epilepsy drug trial success
- UPDATE 3-Zogenix stock soars on epilepsy drug trial success